| 1 | t | 20,473 |
| 2 | nk | 1,007 |
| 3 | treg | 459 |
| 4 | cik | 96 |
| 5 | mibi | 45 |
| 6 | lak | 23 |
| 7 | tc1 | 23 |
| 8 | teff | 20 |
| 9 | unk | 20 |
| 10 | pto | 18 |
| 11 | t3-l1 | 17 |
| 12 | t-regulatory | 15 |
| 13 | dnk | 14 |
| 14 | hapi | 13 |
| 15 | hla-dr+ | 12 |
| 16 | t/b | 12 |
| 17 | mφ | 9 |
| 18 | equus | 8 |
| 19 | gh3 | 8 |
| 20 | spot-forming | 8 |
| 21 | ccd-18co | 7 |
| 22 | cd45ro+ | 7 |
| 23 | df1 | 7 |
| 24 | ho-8910 | 7 |
| 25 | nci-h1703 | 7 |
| 26 | svc+can | 7 |
| 27 | anti-t | 6 |
| 28 | anvil | 6 |
| 29 | cb-cik | 6 |
| 30 | docgl | 6 |
| 31 | glides | 6 |
| 32 | hpdl | 6 |
| 33 | bc-3 | 5 |
| 34 | cd16- | 5 |
| 35 | cd4+cd62l+ | 5 |
| 36 | hesi | 5 |
| 37 | hr-01 | 5 |
| 38 | n27 | 5 |
| 39 | prepd | 5 |
| 40 | vcap | 5 |
| 41 | 1/ro | 4 |
| 42 | balb/3t3 | 4 |
| 43 | barcl-95 | 4 |
| 44 | cd127lo | 4 |
| 45 | cd14+cd16+ | 4 |
| 46 | l4-l2/3 | 4 |
| 47 | n6- | 4 |
| 48 | sp+ | 4 |
| 49 | t/3 | 4 |
| 50 | tyr-p | 4 |
| 51 | αoh | 4 |
| 52 | -mcf-7 | 3 |
| 53 | -nf2 | 3 |
| 54 | /=38.5 | 3 |
| 55 | 18/min | 3 |
| 56 | 2/t | 3 |
| 57 | amixin | 3 |
| 58 | bshvs | 3 |
| 59 | cd14dimcd16+ | 3 |
| 60 | cd16/56+ | 3 |
| 61 | colo320dm | 3 |
| 62 | dcf/ha | 3 |
| 63 | dotting | 3 |
| 64 | ecc1 | 3 |
| 65 | eh31 | 3 |
| 66 | h17e2 | 3 |
| 67 | hnet | 3 |
| 68 | iose-385 | 3 |
| 69 | m27 | 3 |
| 70 | modma1 | 3 |
| 71 | ms74 | 3 |
| 72 | nflv | 3 |
| 73 | nlys | 3 |
| 74 | p-cef | 3 |
| 75 | pc3m | 3 |
| 76 | r-r1/r-r2 | 3 |
| 77 | siegmund | 3 |
| 78 | silver-plated | 3 |
| 79 | susa | 3 |
| 80 | tet-off | 3 |
| 81 | th17/tc17 | 3 |
| 82 | trap-positive | 3 |
| 83 | αβt | 3 |
| 84 | ≥39°c | 3 |
| 85 | 0.5cm | 2 |
| 86 | 1,500x10 | 2 |
| 87 | 1.9×10 | 2 |
| 88 | 135mm | 2 |
| 89 | 37.49°c | 2 |
| 90 | 3×10³ | 2 |
| 91 | 4mic | 2 |
| 92 | 5g/l | 2 |
| 93 | 73.26 | 2 |
| 94 | 7mmol/l | 2 |
| 95 | 99tcm-methoxyisobutylisonitrile | 2 |
| 96 | a427/nci-h2073 | 2 |
| 97 | ag1522 | 2 |
| 98 | albustix | 2 |
| 99 | amnisure | 2 |
| 100 | app-sw-nucleofected | 2 |
| 101 | bmc9 | 2 |
| 102 | bme-uv | 2 |
| 103 | bmpria | 2 |
| 104 | br-102 | 2 |
| 105 | c-cup | 2 |
| 106 | c/4a4b/894g | 2 |
| 107 | cahb1 | 2 |
| 108 | carboxymethyl-cellulose | 2 |
| 109 | carehpv™ | 2 |
| 110 | caspase-3-immunoreactive | 2 |
| 111 | cd3-cd16+cd56+ | 2 |
| 112 | chl/iu | 2 |
| 113 | ck+ | 2 |
| 114 | cs+svc+can | 2 |
| 115 | d54mg | 2 |
| 116 | dicqa | 2 |
| 117 | difference=0.68 | 2 |
| 118 | dysplasia/metaplasia | 2 |
| 119 | gp91phox-/- | 2 |
| 120 | h1299/icam-3 | 2 |
| 121 | h1299/pcdna3 | 2 |
| 122 | hbec | 2 |
| 123 | hep-4iie | 2 |
| 124 | hk‑2 | 2 |
| 125 | hmt100 | 2 |
| 126 | ho-1-u-1 | 2 |
| 127 | hp/tf | 2 |
| 128 | hsc-1 | 2 |
| 129 | ion-treated | 2 |
| 130 | leger | 2 |
| 131 | lg2 | 2 |
| 132 | lin- | 2 |
| 133 | line-1/lacz | 2 |
| 134 | ln-lak | 2 |
| 135 | lpbd | 2 |
| 136 | lsk | 2 |
| 137 | m0,2 | 2 |
| 138 | m21-l | 2 |
| 139 | mcf-7-a20 | 2 |
| 140 | mde6 | 2 |
| 141 | methoxyisobutylisonitrile | 2 |
| 142 | micronucleous | 2 |
| 143 | nci-h1975/nci-h200 | 2 |
| 144 | neun-positive | 2 |
| 145 | nleu | 2 |
| 146 | on-bipolar | 2 |
| 147 | or=as | 2 |
| 148 | or=sb | 2 |
| 149 | palatal/lingual | 2 |
| 150 | par-1a/t | 2 |
| 151 | plsd | 2 |
| 152 | r-305 | 2 |
| 153 | r-dependent | 2 |
| 154 | rh/k30 | 2 |
| 155 | rvpac | 2 |
| 156 | single-positive | 2 |
| 157 | supt1 | 2 |
| 158 | t-b | 2 |
| 159 | t-cell-related | 2 |
| 160 | tapir | 2 |
| 161 | th-immunoreactive | 2 |
| 162 | time-to-stabilisation | 2 |
| 163 | tm1n3 | 2 |
| 164 | tnf-α+ | 2 |
| 165 | v444a | 2 |
| 166 | xylan-chitooligomer | 2 |
| 167 | yamc | 2 |
| 168 | zr-75-1a | 2 |
| 169 | zr-75-1s | 2 |
| 170 | ~l | 2 |
| 171 | +/-100 | 1 |
| 172 | +196 | 1 |
| 173 | -15-expressing | 1 |
| 174 | -1501-transformed | 1 |
| 175 | -2-producing | 1 |
| 176 | -293t | 1 |
| 177 | -3-infected/transfected | 1 |
| 178 | -3-regulated | 1 |
| 179 | -erythema | 1 |
| 180 | -fluorophosphate | 1 |
| 181 | -hnis/tdtomato | 1 |
| 182 | -immunopositive | 1 |
| 183 | -me | 1 |
| 184 | -t-lymphocytes | 1 |
| 185 | -t6 | 1 |
| 186 | -will | 1 |
| 187 | /=0.55 | 1 |
| 188 | /=10.8cms | 1 |
| 189 | /=100/mm | 1 |
| 190 | /== | 1 |
| 191 | /graphite | 1 |
| 192 | /lithium | 1 |
| 193 | /nh3/nh4+ | 1 |
| 194 | /programmed | 1 |
| 195 | /squamous | 1 |
| 196 | /stem | 1 |
| 197 | 0.05×10 | 1 |
| 198 | 1-methyl-2-pyrrolidinone | 1 |
| 199 | 10/mm | 1 |
| 200 | 100/200,000 | 1 |
| 201 | 1000mgkg | 1 |
| 202 | 1024/ | 1 |
| 203 | 107,894 | 1 |
| 204 | 1229.55m | 1 |
| 205 | 12m/s | 1 |
| 206 | 1500mgkg | 1 |
| 207 | 150mg/dl | 1 |
| 208 | 16,002 | 1 |
| 209 | 16,635 | 1 |
| 210 | 17,405 | 1 |
| 211 | 18,068 | 1 |
| 212 | 180/ | 1 |
| 213 | 188+/-15 | 1 |
| 214 | 1×/day | 1 |
| 215 | 2,2,6,6-tetramethyl-4-piperidone | 1 |
| 216 | 2,4-oh | 1 |
| 217 | 2,6-dimethyl-3-pyridinol | 1 |
| 218 | 2-etim | 1 |
| 219 | 2-meim | 1 |
| 220 | 2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone | 1 |
| 221 | 2-picoline | 1 |
| 222 | 2-pyrrolidinone | 1 |
| 223 | 20-≤25yrs | 1 |
| 224 | 200cells/mm | 1 |
| 225 | 201-5713 | 1 |
| 226 | 20leukocytes/mm | 1 |
| 227 | 210/ | 1 |
| 228 | 23-827 | 1 |
| 229 | 25,024 | 1 |
| 230 | 25-≤30yrs | 1 |
| 231 | 26,733 | 1 |
| 232 | 27oe | 1 |
| 233 | 2xuln | 1 |
| 234 | 3,4-oh | 1 |
| 235 | 3,4-ome | 1 |
| 236 | 3,5-ome-4-oh | 1 |
| 237 | 3,981.88×10 | 1 |
| 238 | 3-hexanoyloxy-2-methoxy-5-methyl-1,4-benzoquinone | 1 |
| 239 | 3-me-4-ome | 1 |
| 240 | 3-ome-4-oh | 1 |
| 241 | 3.2-2.62å | 1 |
| 242 | 3.2-2.67å | 1 |
| 243 | 3.36mmol.l | 1 |
| 244 | 3.4×10 | 1 |
| 245 | 30yrs | 1 |
| 246 | 30×10³ | 1 |
| 247 | 33,744 | 1 |
| 248 | 348.9 | 1 |
| 249 | 3a7 | 1 |
| 250 | 3f4 | 1 |
| 251 | 4-fqa | 1 |
| 252 | 4.8mg/dl | 1 |
| 253 | 400/mm | 1 |
| 254 | 49,534.75 | 1 |
| 255 | 4mmol·l | 1 |
| 256 | 5-fqa | 1 |
| 257 | 5.7mgdl | 1 |
| 258 | 50,895.73 | 1 |
| 259 | 50pgg | 1 |
| 260 | 60/sc | 1 |
| 261 | 6mmol/l | 1 |
| 262 | 7.0mgdl | 1 |
| 263 | 8.2x10 | 1 |
| 264 | 8000/mm | 1 |
| 265 | 85/min | 1 |
| 266 | 85beats/min | 1 |
| 267 | 85bpm | 1 |
| 268 | 9,428 | 1 |
| 269 | 90mgdl | 1 |
| 270 | 90x10 | 1 |
| 271 | ==10mg/day | 1 |
| 272 | a-mechanoheat | 1 |
| 273 | a431-cck2r | 1 |
| 274 | activitives | 1 |
| 275 | adelung | 1 |
| 276 | alpha-cd | 1 |
| 277 | alpha2a-ar | 1 |
| 278 | alpha2b-ar | 1 |
| 279 | app-wt-nucleofected | 1 |
| 280 | atcc700040 | 1 |
| 281 | beta+t | 1 |
| 282 | bodies™+ | 1 |
| 283 | bourgelat | 1 |
| 284 | buddhadasa | 1 |
| 285 | bushehr | 1 |
| 286 | c-kit/8-hydroxydeoxyguanosine-positive | 1 |
| 287 | c-kit/mefc2/gata4-positive | 1 |
| 288 | c-kit/p16ink4a-positive | 1 |
| 289 | cc-5min | 1 |
| 290 | cc-60min | 1 |
| 291 | ccl-17 | 1 |
| 292 | cd34+/kdr+/cd45dim/- | 1 |
| 293 | cd4+/cd25+ | 1 |
| 294 | cd4/foxp3 | 1 |
| 295 | cd45+/procollagen-1+ | 1 |
| 296 | cd45ra+cd62l | 1 |
| 297 | cd56dim | 1 |
| 298 | cd8+/ki67+ | 1 |
| 299 | cheart | 1 |
| 300 | cho-h1/beta2 | 1 |
| 301 | chochinov | 1 |
| 302 | cholesterol-25-hydroxylase | 1 |
| 303 | ckidney | 1 |
| 304 | cm-240min | 1 |
| 305 | cm-30min | 1 |
| 306 | cm-5min | 1 |
| 307 | cm-60min | 1 |
| 308 | cns-gliosarcoma-sf295 | 1 |
| 309 | cochenillifera | 1 |
| 310 | coldwu | 1 |
| 311 | count/percentage | 1 |
| 312 | cspleen | 1 |
| 313 | ctla-4+ | 1 |
| 314 | cts-score | 1 |
| 315 | cttca | 1 |
| 316 | cvc=red | 1 |
| 317 | cytokeratin-positive | 1 |
| 318 | da-3 | 1 |
| 319 | denv1~denv2 | 1 |
| 320 | desal3b | 1 |
| 321 | di2/dz≈- | 1 |
| 322 | dose/maximum | 1 |
| 323 | dutugemunu | 1 |
| 324 | e/dt2=2cjj | 1 |
| 325 | ebv/p24-carrying | 1 |
| 326 | eca‑109/neo | 1 |
| 327 | eicosanoate | 1 |
| 328 | emulgal | 1 |
| 329 | ept-phbv-s | 1 |
| 330 | esfahan | 1 |
| 331 | e≡∫ | 1 |
| 332 | factor11 | 1 |
| 333 | fixed-flexion | 1 |
| 334 | fna-mct | 1 |
| 335 | g20-n/g20-a | 1 |
| 336 | gaps/endothelial | 1 |
| 337 | gene-traf4 | 1 |
| 338 | ghf-n/ghf-a | 1 |
| 339 | gilan | 1 |
| 340 | glucoheptonate | 1 |
| 341 | hovcar-3 | 1 |
| 342 | hr-24 | 1 |
| 343 | hssca-11 | 1 |
| 344 | il-10-expressing | 1 |
| 345 | imr90 | 1 |
| 346 | inipol | 1 |
| 347 | iof-treated | 1 |
| 348 | leukocyte/bands | 1 |
| 349 | lf-sd | 1 |
| 350 | ligand-producing | 1 |
| 351 | locd4+ | 1 |
| 352 | lymphocytes/10,000 | 1 |
| 353 | lymphomononuclear | 1 |
| 354 | mac-t | 1 |
| 355 | mda-cox-2 | 1 |
| 356 | mda-mb-436 | 1 |
| 357 | mil-100-fe | 1 |
| 358 | ml±103.5 | 1 |
| 359 | munc18-1-deficient | 1 |
| 360 | myeloperoxidase-positive | 1 |
| 361 | neutrophil-endotheliocytes | 1 |
| 362 | nica | 1 |
| 363 | non-parameter | 1 |
| 364 | or=100/mm | 1 |
| 365 | or=130/ | 1 |
| 366 | or=20/ | 1 |
| 367 | or=25.0kg/m | 1 |
| 368 | or=cu | 1 |
| 369 | or=ii | 1 |
| 370 | p53-immunoreactive | 1 |
| 371 | pan-endothelial | 1 |
| 372 | pan-tnox | 1 |
| 373 | patriot | 1 |
| 374 | per-a | 1 |
| 375 | pes~zes | 1 |
| 376 | petrotech | 1 |
| 377 | pmel-1-specific | 1 |
| 378 | primary-blood | 1 |
| 379 | promitotic | 1 |
| 380 | protein-1-directed | 1 |
| 381 | protein-1-immunopositive | 1 |
| 382 | protein-beta | 1 |
| 383 | puerarin-berberine | 1 |
| 384 | q-tests | 1 |
| 385 | q=13.85 | 1 |
| 386 | renca-egfp-sorted | 1 |
| 387 | rm-im | 1 |
| 388 | sample-t | 1 |
| 389 | sepa-ms05 | 1 |
| 390 | skimmed-milk-based | 1 |
| 391 | smear/hpv | 1 |
| 392 | t-13910 | 1 |
| 393 | tcg=tcg+av | 1 |
| 394 | type-2-ebv-infected | 1 |
| 395 | u87mg.δegfr | 1 |
| 396 | va-storaging | 1 |
| 397 | vegfr-2+ | 1 |
| 398 | vβ8 | 1 |
| 399 | w/continuous | 1 |
| 400 | α=0.38 | 1 |
| 401 | αklothoβ | 1 |
| 402 | σ-valerolactam | 1 |
| 403 | ≈1600 | 1 |
| 404 | ≈g | 1 |
| 1 | +/-100 | 1 |
| 2 | +196 | 1 |
| 3 | -15-expressing | 1 |
| 4 | -1501-transformed | 1 |
| 5 | -2-producing | 1 |
| 6 | -293t | 1 |
| 7 | -3-infected/transfected | 1 |
| 8 | -3-regulated | 1 |
| 9 | -erythema | 1 |
| 10 | -fluorophosphate | 1 |
| 11 | -hnis/tdtomato | 1 |
| 12 | -immunopositive | 1 |
| 13 | -mcf-7 | 3 |
| 14 | -me | 1 |
| 15 | -nf2 | 3 |
| 16 | -t-lymphocytes | 1 |
| 17 | -t6 | 1 |
| 18 | -will | 1 |
| 19 | /=0.55 | 1 |
| 20 | /=10.8cms | 1 |
| 21 | /=100/mm | 1 |
| 22 | /=38.5 | 3 |
| 23 | /== | 1 |
| 24 | /graphite | 1 |
| 25 | /lithium | 1 |
| 26 | /nh3/nh4+ | 1 |
| 27 | /programmed | 1 |
| 28 | /squamous | 1 |
| 29 | /stem | 1 |
| 30 | 0.05×10 | 1 |
| 31 | 0.5cm | 2 |
| 32 | 1,500x10 | 2 |
| 33 | 1-methyl-2-pyrrolidinone | 1 |
| 34 | 1.9×10 | 2 |
| 35 | 1/ro | 4 |
| 36 | 10/mm | 1 |
| 37 | 100/200,000 | 1 |
| 38 | 1000mgkg | 1 |
| 39 | 1024/ | 1 |
| 40 | 107,894 | 1 |
| 41 | 1229.55m | 1 |
| 42 | 12m/s | 1 |
| 43 | 135mm | 2 |
| 44 | 1500mgkg | 1 |
| 45 | 150mg/dl | 1 |
| 46 | 16,002 | 1 |
| 47 | 16,635 | 1 |
| 48 | 17,405 | 1 |
| 49 | 18,068 | 1 |
| 50 | 18/min | 3 |
| 51 | 180/ | 1 |
| 52 | 188+/-15 | 1 |
| 53 | 1×/day | 1 |
| 54 | 2,2,6,6-tetramethyl-4-piperidone | 1 |
| 55 | 2,4-oh | 1 |
| 56 | 2,6-dimethyl-3-pyridinol | 1 |
| 57 | 2-etim | 1 |
| 58 | 2-meim | 1 |
| 59 | 2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone | 1 |
| 60 | 2-picoline | 1 |
| 61 | 2-pyrrolidinone | 1 |
| 62 | 2/t | 3 |
| 63 | 20-≤25yrs | 1 |
| 64 | 200cells/mm | 1 |
| 65 | 201-5713 | 1 |
| 66 | 20leukocytes/mm | 1 |
| 67 | 210/ | 1 |
| 68 | 23-827 | 1 |
| 69 | 25,024 | 1 |
| 70 | 25-≤30yrs | 1 |
| 71 | 26,733 | 1 |
| 72 | 27oe | 1 |
| 73 | 2xuln | 1 |
| 74 | 3,4-oh | 1 |
| 75 | 3,4-ome | 1 |
| 76 | 3,5-ome-4-oh | 1 |
| 77 | 3,981.88×10 | 1 |
| 78 | 3-hexanoyloxy-2-methoxy-5-methyl-1,4-benzoquinone | 1 |
| 79 | 3-me-4-ome | 1 |
| 80 | 3-ome-4-oh | 1 |
| 81 | 3.2-2.62å | 1 |
| 82 | 3.2-2.67å | 1 |
| 83 | 3.36mmol.l | 1 |
| 84 | 3.4×10 | 1 |
| 85 | 30yrs | 1 |
| 86 | 30×10³ | 1 |
| 87 | 33,744 | 1 |
| 88 | 348.9 | 1 |
| 89 | 37.49°c | 2 |
| 90 | 3a7 | 1 |
| 91 | 3f4 | 1 |
| 92 | 3×10³ | 2 |
| 93 | 4-fqa | 1 |
| 94 | 4.8mg/dl | 1 |
| 95 | 400/mm | 1 |
| 96 | 49,534.75 | 1 |
| 97 | 4mic | 2 |
| 98 | 4mmol·l | 1 |
| 99 | 5-fqa | 1 |
| 100 | 5.7mgdl | 1 |
| 101 | 50,895.73 | 1 |
| 102 | 50pgg | 1 |
| 103 | 5g/l | 2 |
| 104 | 60/sc | 1 |
| 105 | 6mmol/l | 1 |
| 106 | 7.0mgdl | 1 |
| 107 | 73.26 | 2 |
| 108 | 7mmol/l | 2 |
| 109 | 8.2x10 | 1 |
| 110 | 8000/mm | 1 |
| 111 | 85/min | 1 |
| 112 | 85beats/min | 1 |
| 113 | 85bpm | 1 |
| 114 | 9,428 | 1 |
| 115 | 90mgdl | 1 |
| 116 | 90x10 | 1 |
| 117 | 99tcm-methoxyisobutylisonitrile | 2 |
| 118 | ==10mg/day | 1 |
| 119 | a-mechanoheat | 1 |
| 120 | a427/nci-h2073 | 2 |
| 121 | a431-cck2r | 1 |
| 122 | activitives | 1 |
| 123 | adelung | 1 |
| 124 | ag1522 | 2 |
| 125 | albustix | 2 |
| 126 | alpha-cd | 1 |
| 127 | alpha2a-ar | 1 |
| 128 | alpha2b-ar | 1 |
| 129 | amixin | 3 |
| 130 | amnisure | 2 |
| 131 | anti-t | 6 |
| 132 | anvil | 6 |
| 133 | app-sw-nucleofected | 2 |
| 134 | app-wt-nucleofected | 1 |
| 135 | atcc700040 | 1 |
| 136 | balb/3t3 | 4 |
| 137 | barcl-95 | 4 |
| 138 | bc-3 | 5 |
| 139 | beta+t | 1 |
| 140 | bmc9 | 2 |
| 141 | bme-uv | 2 |
| 142 | bmpria | 2 |
| 143 | bodies™+ | 1 |
| 144 | bourgelat | 1 |
| 145 | br-102 | 2 |
| 146 | bshvs | 3 |
| 147 | buddhadasa | 1 |
| 148 | bushehr | 1 |
| 149 | c-cup | 2 |
| 150 | c-kit/8-hydroxydeoxyguanosine-positive | 1 |
| 151 | c-kit/mefc2/gata4-positive | 1 |
| 152 | c-kit/p16ink4a-positive | 1 |
| 153 | c/4a4b/894g | 2 |
| 154 | cahb1 | 2 |
| 155 | carboxymethyl-cellulose | 2 |
| 156 | carehpv™ | 2 |
| 157 | caspase-3-immunoreactive | 2 |
| 158 | cb-cik | 6 |
| 159 | cc-5min | 1 |
| 160 | cc-60min | 1 |
| 161 | ccd-18co | 7 |
| 162 | ccl-17 | 1 |
| 163 | cd127lo | 4 |
| 164 | cd14+cd16+ | 4 |
| 165 | cd14dimcd16+ | 3 |
| 166 | cd16- | 5 |
| 167 | cd16/56+ | 3 |
| 168 | cd3-cd16+cd56+ | 2 |
| 169 | cd34+/kdr+/cd45dim/- | 1 |
| 170 | cd4+/cd25+ | 1 |
| 171 | cd4+cd62l+ | 5 |
| 172 | cd4/foxp3 | 1 |
| 173 | cd45+/procollagen-1+ | 1 |
| 174 | cd45ra+cd62l | 1 |
| 175 | cd45ro+ | 7 |
| 176 | cd56dim | 1 |
| 177 | cd8+/ki67+ | 1 |
| 178 | cheart | 1 |
| 179 | chl/iu | 2 |
| 180 | cho-h1/beta2 | 1 |
| 181 | chochinov | 1 |
| 182 | cholesterol-25-hydroxylase | 1 |
| 183 | cik | 96 |
| 184 | ck+ | 2 |
| 185 | ckidney | 1 |
| 186 | cm-240min | 1 |
| 187 | cm-30min | 1 |
| 188 | cm-5min | 1 |
| 189 | cm-60min | 1 |
| 190 | cns-gliosarcoma-sf295 | 1 |
| 191 | cochenillifera | 1 |
| 192 | coldwu | 1 |
| 193 | colo320dm | 3 |
| 194 | count/percentage | 1 |
| 195 | cs+svc+can | 2 |
| 196 | cspleen | 1 |
| 197 | ctla-4+ | 1 |
| 198 | cts-score | 1 |
| 199 | cttca | 1 |
| 200 | cvc=red | 1 |
| 201 | cytokeratin-positive | 1 |
| 202 | d54mg | 2 |
| 203 | da-3 | 1 |
| 204 | dcf/ha | 3 |
| 205 | denv1~denv2 | 1 |
| 206 | desal3b | 1 |
| 207 | df1 | 7 |
| 208 | di2/dz≈- | 1 |
| 209 | dicqa | 2 |
| 210 | difference=0.68 | 2 |
| 211 | dnk | 14 |
| 212 | docgl | 6 |
| 213 | dose/maximum | 1 |
| 214 | dotting | 3 |
| 215 | dutugemunu | 1 |
| 216 | dysplasia/metaplasia | 2 |
| 217 | e/dt2=2cjj | 1 |
| 218 | ebv/p24-carrying | 1 |
| 219 | eca‑109/neo | 1 |
| 220 | ecc1 | 3 |
| 221 | eh31 | 3 |
| 222 | eicosanoate | 1 |
| 223 | emulgal | 1 |
| 224 | ept-phbv-s | 1 |
| 225 | equus | 8 |
| 226 | esfahan | 1 |
| 227 | e≡∫ | 1 |
| 228 | factor11 | 1 |
| 229 | fixed-flexion | 1 |
| 230 | fna-mct | 1 |
| 231 | g20-n/g20-a | 1 |
| 232 | gaps/endothelial | 1 |
| 233 | gene-traf4 | 1 |
| 234 | gh3 | 8 |
| 235 | ghf-n/ghf-a | 1 |
| 236 | gilan | 1 |
| 237 | glides | 6 |
| 238 | glucoheptonate | 1 |
| 239 | gp91phox-/- | 2 |
| 240 | h1299/icam-3 | 2 |
| 241 | h1299/pcdna3 | 2 |
| 242 | h17e2 | 3 |
| 243 | hapi | 13 |
| 244 | hbec | 2 |
| 245 | hep-4iie | 2 |
| 246 | hesi | 5 |
| 247 | hk‑2 | 2 |
| 248 | hla-dr+ | 12 |
| 249 | hmt100 | 2 |
| 250 | hnet | 3 |
| 251 | ho-1-u-1 | 2 |
| 252 | ho-8910 | 7 |
| 253 | hovcar-3 | 1 |
| 254 | hp/tf | 2 |
| 255 | hpdl | 6 |
| 256 | hr-01 | 5 |
| 257 | hr-24 | 1 |
| 258 | hsc-1 | 2 |
| 259 | hssca-11 | 1 |
| 260 | il-10-expressing | 1 |
| 261 | imr90 | 1 |
| 262 | inipol | 1 |
| 263 | iof-treated | 1 |
| 264 | ion-treated | 2 |
| 265 | iose-385 | 3 |
| 266 | l4-l2/3 | 4 |
| 267 | lak | 23 |
| 268 | leger | 2 |
| 269 | leukocyte/bands | 1 |
| 270 | lf-sd | 1 |
| 271 | lg2 | 2 |
| 272 | ligand-producing | 1 |
| 273 | lin- | 2 |
| 274 | line-1/lacz | 2 |
| 275 | ln-lak | 2 |
| 276 | locd4+ | 1 |
| 277 | lpbd | 2 |
| 278 | lsk | 2 |
| 279 | lymphocytes/10,000 | 1 |
| 280 | lymphomononuclear | 1 |
| 281 | m0,2 | 2 |
| 282 | m21-l | 2 |
| 283 | m27 | 3 |
| 284 | mac-t | 1 |
| 285 | mcf-7-a20 | 2 |
| 286 | mda-cox-2 | 1 |
| 287 | mda-mb-436 | 1 |
| 288 | mde6 | 2 |
| 289 | methoxyisobutylisonitrile | 2 |
| 290 | mibi | 45 |
| 291 | micronucleous | 2 |
| 292 | mil-100-fe | 1 |
| 293 | ml±103.5 | 1 |
| 294 | modma1 | 3 |
| 295 | ms74 | 3 |
| 296 | munc18-1-deficient | 1 |
| 297 | myeloperoxidase-positive | 1 |
| 298 | mφ | 9 |
| 299 | n27 | 5 |
| 300 | n6- | 4 |
| 301 | nci-h1703 | 7 |
| 302 | nci-h1975/nci-h200 | 2 |
| 303 | neun-positive | 2 |
| 304 | neutrophil-endotheliocytes | 1 |
| 305 | nflv | 3 |
| 306 | nica | 1 |
| 307 | nk | 1,007 |
| 308 | nleu | 2 |
| 309 | nlys | 3 |
| 310 | non-parameter | 1 |
| 311 | on-bipolar | 2 |
| 312 | or=100/mm | 1 |
| 313 | or=130/ | 1 |
| 314 | or=20/ | 1 |
| 315 | or=25.0kg/m | 1 |
| 316 | or=as | 2 |
| 317 | or=cu | 1 |
| 318 | or=ii | 1 |
| 319 | or=sb | 2 |
| 320 | p-cef | 3 |
| 321 | p53-immunoreactive | 1 |
| 322 | palatal/lingual | 2 |
| 323 | pan-endothelial | 1 |
| 324 | pan-tnox | 1 |
| 325 | par-1a/t | 2 |
| 326 | patriot | 1 |
| 327 | pc3m | 3 |
| 328 | per-a | 1 |
| 329 | pes~zes | 1 |
| 330 | petrotech | 1 |
| 331 | plsd | 2 |
| 332 | pmel-1-specific | 1 |
| 333 | prepd | 5 |
| 334 | primary-blood | 1 |
| 335 | promitotic | 1 |
| 336 | protein-1-directed | 1 |
| 337 | protein-1-immunopositive | 1 |
| 338 | protein-beta | 1 |
| 339 | pto | 18 |
| 340 | puerarin-berberine | 1 |
| 341 | q-tests | 1 |
| 342 | q=13.85 | 1 |
| 343 | r-305 | 2 |
| 344 | r-dependent | 2 |
| 345 | r-r1/r-r2 | 3 |
| 346 | renca-egfp-sorted | 1 |
| 347 | rh/k30 | 2 |
| 348 | rm-im | 1 |
| 349 | rvpac | 2 |
| 350 | sample-t | 1 |
| 351 | sepa-ms05 | 1 |
| 352 | siegmund | 3 |
| 353 | silver-plated | 3 |
| 354 | single-positive | 2 |
| 355 | skimmed-milk-based | 1 |
| 356 | smear/hpv | 1 |
| 357 | sp+ | 4 |
| 358 | spot-forming | 8 |
| 359 | supt1 | 2 |
| 360 | susa | 3 |
| 361 | svc+can | 7 |
| 362 | t | 20,473 |
| 363 | t-13910 | 1 |
| 364 | t-b | 2 |
| 365 | t-cell-related | 2 |
| 366 | t-regulatory | 15 |
| 367 | t/3 | 4 |
| 368 | t/b | 12 |
| 369 | t3-l1 | 17 |
| 370 | tapir | 2 |
| 371 | tc1 | 23 |
| 372 | tcg=tcg+av | 1 |
| 373 | teff | 20 |
| 374 | tet-off | 3 |
| 375 | th-immunoreactive | 2 |
| 376 | th17/tc17 | 3 |
| 377 | time-to-stabilisation | 2 |
| 378 | tm1n3 | 2 |
| 379 | tnf-α+ | 2 |
| 380 | trap-positive | 3 |
| 381 | treg | 459 |
| 382 | type-2-ebv-infected | 1 |
| 383 | tyr-p | 4 |
| 384 | u87mg.δegfr | 1 |
| 385 | unk | 20 |
| 386 | v444a | 2 |
| 387 | va-storaging | 1 |
| 388 | vcap | 5 |
| 389 | vegfr-2+ | 1 |
| 390 | vβ8 | 1 |
| 391 | w/continuous | 1 |
| 392 | xylan-chitooligomer | 2 |
| 393 | yamc | 2 |
| 394 | zr-75-1a | 2 |
| 395 | zr-75-1s | 2 |
| 396 | ~l | 2 |
| 397 | α=0.38 | 1 |
| 398 | αklothoβ | 1 |
| 399 | αoh | 4 |
| 400 | αβt | 3 |
| 401 | σ-valerolactam | 1 |
| 402 | ≈1600 | 1 |
| 403 | ≈g | 1 |
| 404 | ≥39°c | 3 |
| 1 | cd45+/procollagen-1+ | 1 |
| 2 | vegfr-2+ | 1 |
| 3 | ctla-4+ | 1 |
| 4 | locd4+ | 1 |
| 5 | /nh3/nh4+ | 1 |
| 6 | cd4+/cd25+ | 1 |
| 7 | cd14+cd16+ | 4 |
| 8 | cd14dimcd16+ | 3 |
| 9 | cd16/56+ | 3 |
| 10 | cd3-cd16+cd56+ | 2 |
| 11 | cd8+/ki67+ | 1 |
| 12 | ck+ | 2 |
| 13 | cd4+cd62l+ | 5 |
| 14 | cd45ro+ | 7 |
| 15 | sp+ | 4 |
| 16 | hla-dr+ | 12 |
| 17 | bodies™+ | 1 |
| 18 | tnf-α+ | 2 |
| 19 | gp91phox-/- | 2 |
| 20 | cd34+/kdr+/cd45dim/- | 1 |
| 21 | cd16- | 5 |
| 22 | n6- | 4 |
| 23 | lin- | 2 |
| 24 | di2/dz≈- | 1 |
| 25 | 210/ | 1 |
| 26 | or=20/ | 1 |
| 27 | or=130/ | 1 |
| 28 | 180/ | 1 |
| 29 | 1024/ | 1 |
| 30 | 100/200,000 | 1 |
| 31 | lymphocytes/10,000 | 1 |
| 32 | +/-100 | 1 |
| 33 | hmt100 | 2 |
| 34 | nci-h1975/nci-h200 | 2 |
| 35 | ≈1600 | 1 |
| 36 | t-13910 | 1 |
| 37 | ho-8910 | 7 |
| 38 | 1,500x10 | 2 |
| 39 | 90x10 | 1 |
| 40 | 8.2x10 | 1 |
| 41 | 3.4×10 | 1 |
| 42 | 0.05×10 | 1 |
| 43 | 3,981.88×10 | 1 |
| 44 | 1.9×10 | 2 |
| 45 | mcf-7-a20 | 2 |
| 46 | rh/k30 | 2 |
| 47 | atcc700040 | 1 |
| 48 | imr90 | 1 |
| 49 | hsc-1 | 2 |
| 50 | ho-1-u-1 | 2 |
| 51 | hr-01 | 5 |
| 52 | hssca-11 | 1 |
| 53 | factor11 | 1 |
| 54 | eh31 | 3 |
| 55 | modma1 | 3 |
| 56 | cahb1 | 2 |
| 57 | ecc1 | 3 |
| 58 | tc1 | 23 |
| 59 | df1 | 7 |
| 60 | t3-l1 | 17 |
| 61 | supt1 | 2 |
| 62 | m0,2 | 2 |
| 63 | mda-cox-2 | 1 |
| 64 | 16,002 | 1 |
| 65 | br-102 | 2 |
| 66 | ag1522 | 2 |
| 67 | cho-h1/beta2 | 1 |
| 68 | h17e2 | 3 |
| 69 | -nf2 | 3 |
| 70 | lg2 | 2 |
| 71 | r-r1/r-r2 | 3 |
| 72 | denv1~denv2 | 1 |
| 73 | hk‑2 | 2 |
| 74 | da-3 | 1 |
| 75 | bc-3 | 5 |
| 76 | h1299/icam-3 | 2 |
| 77 | hovcar-3 | 1 |
| 78 | l4-l2/3 | 4 |
| 79 | t/3 | 4 |
| 80 | nci-h1703 | 7 |
| 81 | 201-5713 | 1 |
| 82 | 26,733 | 1 |
| 83 | 50,895.73 | 1 |
| 84 | a427/nci-h2073 | 2 |
| 85 | h1299/pcdna3 | 2 |
| 86 | gh3 | 8 |
| 87 | tm1n3 | 2 |
| 88 | cd4/foxp3 | 1 |
| 89 | balb/3t3 | 4 |
| 90 | hr-24 | 1 |
| 91 | 25,024 | 1 |
| 92 | 33,744 | 1 |
| 93 | ms74 | 3 |
| 94 | 107,894 | 1 |
| 95 | 3f4 | 1 |
| 96 | gene-traf4 | 1 |
| 97 | ml±103.5 | 1 |
| 98 | /=38.5 | 3 |
| 99 | r-305 | 2 |
| 100 | 17,405 | 1 |
| 101 | sepa-ms05 | 1 |
| 102 | 188+/-15 | 1 |
| 103 | 16,635 | 1 |
| 104 | /=0.55 | 1 |
| 105 | 49,534.75 | 1 |
| 106 | q=13.85 | 1 |
| 107 | iose-385 | 3 |
| 108 | barcl-95 | 4 |
| 109 | cns-gliosarcoma-sf295 | 1 |
| 110 | 73.26 | 2 |
| 111 | mda-mb-436 | 1 |
| 112 | +196 | 1 |
| 113 | mde6 | 2 |
| 114 | -t6 | 1 |
| 115 | -mcf-7 | 3 |
| 116 | ccl-17 | 1 |
| 117 | th17/tc17 | 3 |
| 118 | 23-827 | 1 |
| 119 | m27 | 3 |
| 120 | n27 | 5 |
| 121 | 3a7 | 1 |
| 122 | 9,428 | 1 |
| 123 | α=0.38 | 1 |
| 124 | difference=0.68 | 2 |
| 125 | 18,068 | 1 |
| 126 | vβ8 | 1 |
| 127 | 348.9 | 1 |
| 128 | bmc9 | 2 |
| 129 | /== | 1 |
| 130 | g20-n/g20-a | 1 |
| 131 | ghf-n/ghf-a | 1 |
| 132 | per-a | 1 |
| 133 | zr-75-1a | 2 |
| 134 | v444a | 2 |
| 135 | nica | 1 |
| 136 | cttca | 1 |
| 137 | dcf/ha | 3 |
| 138 | bmpria | 2 |
| 139 | dysplasia/metaplasia | 2 |
| 140 | -erythema | 1 |
| 141 | dicqa | 2 |
| 142 | 4-fqa | 1 |
| 143 | 5-fqa | 1 |
| 144 | cochenillifera | 1 |
| 145 | buddhadasa | 1 |
| 146 | susa | 3 |
| 147 | protein-beta | 1 |
| 148 | t-b | 2 |
| 149 | t/b | 12 |
| 150 | desal3b | 1 |
| 151 | or=sb | 2 |
| 152 | rvpac | 2 |
| 153 | hbec | 2 |
| 154 | pmel-1-specific | 1 |
| 155 | 4mic | 2 |
| 156 | promitotic | 1 |
| 157 | yamc | 2 |
| 158 | 60/sc | 1 |
| 159 | ≥39°c | 3 |
| 160 | 37.49°c | 2 |
| 161 | lpbd | 2 |
| 162 | alpha-cd | 1 |
| 163 | /programmed | 1 |
| 164 | -1501-transformed | 1 |
| 165 | cvc=red | 1 |
| 166 | skimmed-milk-based | 1 |
| 167 | iof-treated | 1 |
| 168 | ion-treated | 2 |
| 169 | t-cell-related | 2 |
| 170 | silver-plated | 3 |
| 171 | -3-regulated | 1 |
| 172 | type-2-ebv-infected | 1 |
| 173 | app-wt-nucleofected | 1 |
| 174 | app-sw-nucleofected | 2 |
| 175 | -3-infected/transfected | 1 |
| 176 | protein-1-directed | 1 |
| 177 | renca-egfp-sorted | 1 |
| 178 | siegmund | 3 |
| 179 | primary-blood | 1 |
| 180 | prepd | 5 |
| 181 | lf-sd | 1 |
| 182 | plsd | 2 |
| 183 | mil-100-fe | 1 |
| 184 | count/percentage | 1 |
| 185 | hep-4iie | 2 |
| 186 | methoxyisobutylisonitrile | 2 |
| 187 | 99tcm-methoxyisobutylisonitrile | 2 |
| 188 | -me | 1 |
| 189 | 3,4-ome | 1 |
| 190 | 3-me-4-ome | 1 |
| 191 | 2-picoline | 1 |
| 192 | puerarin-berberine | 1 |
| 193 | 2,2,6,6-tetramethyl-4-piperidone | 1 |
| 194 | 2-pyrrolidinone | 1 |
| 195 | 1-methyl-2-pyrrolidinone | 1 |
| 196 | 3-hexanoyloxy-2-methoxy-5-methyl-1,4-benzoquinone | 1 |
| 197 | 2-methoxy-5-methyl-3-tetradecanoyloxy-1,4-benzoquinone | 1 |
| 198 | 27oe | 1 |
| 199 | cts-score | 1 |
| 200 | amnisure | 2 |
| 201 | cholesterol-25-hydroxylase | 1 |
| 202 | carboxymethyl-cellulose | 2 |
| 203 | -fluorophosphate | 1 |
| 204 | glucoheptonate | 1 |
| 205 | eicosanoate | 1 |
| 206 | /graphite | 1 |
| 207 | caspase-3-immunoreactive | 2 |
| 208 | p53-immunoreactive | 1 |
| 209 | th-immunoreactive | 2 |
| 210 | c-kit/mefc2/gata4-positive | 1 |
| 211 | c-kit/p16ink4a-positive | 1 |
| 212 | single-positive | 2 |
| 213 | c-kit/8-hydroxydeoxyguanosine-positive | 1 |
| 214 | myeloperoxidase-positive | 1 |
| 215 | cytokeratin-positive | 1 |
| 216 | neun-positive | 2 |
| 217 | trap-positive | 3 |
| 218 | -immunopositive | 1 |
| 219 | protein-1-immunopositive | 1 |
| 220 | p-cef | 3 |
| 221 | teff | 20 |
| 222 | tet-off | 3 |
| 223 | hp/tf | 2 |
| 224 | c/4a4b/894g | 2 |
| 225 | treg | 459 |
| 226 | 50pgg | 1 |
| 227 | 1000mgkg | 1 |
| 228 | 1500mgkg | 1 |
| 229 | d54mg | 2 |
| 230 | -2-producing | 1 |
| 231 | ligand-producing | 1 |
| 232 | va-storaging | 1 |
| 233 | spot-forming | 8 |
| 234 | il-10-expressing | 1 |
| 235 | -15-expressing | 1 |
| 236 | dotting | 3 |
| 237 | ebv/p24-carrying | 1 |
| 238 | adelung | 1 |
| 239 | ≈g | 1 |
| 240 | petrotech | 1 |
| 241 | 2,4-oh | 1 |
| 242 | 3,4-oh | 1 |
| 243 | 3-ome-4-oh | 1 |
| 244 | 3,5-ome-4-oh | 1 |
| 245 | αoh | 4 |
| 246 | mibi | 45 |
| 247 | or=ii | 1 |
| 248 | hapi | 13 |
| 249 | hesi | 5 |
| 250 | e/dt2=2cjj | 1 |
| 251 | lak | 23 |
| 252 | ln-lak | 2 |
| 253 | cik | 96 |
| 254 | cb-cik | 6 |
| 255 | nk | 1,007 |
| 256 | dnk | 14 |
| 257 | unk | 20 |
| 258 | lsk | 2 |
| 259 | m21-l | 2 |
| 260 | 3.36mmol.l | 1 |
| 261 | 5g/l | 2 |
| 262 | 6mmol/l | 1 |
| 263 | 7mmol/l | 2 |
| 264 | cd45ra+cd62l | 1 |
| 265 | emulgal | 1 |
| 266 | pan-endothelial | 1 |
| 267 | gaps/endothelial | 1 |
| 268 | palatal/lingual | 2 |
| 269 | 150mg/dl | 1 |
| 270 | 4.8mg/dl | 1 |
| 271 | 7.0mgdl | 1 |
| 272 | 90mgdl | 1 |
| 273 | 5.7mgdl | 1 |
| 274 | hpdl | 6 |
| 275 | docgl | 6 |
| 276 | anvil | 6 |
| 277 | -will | 1 |
| 278 | 2,6-dimethyl-3-pyridinol | 1 |
| 279 | inipol | 1 |
| 280 | ~l | 2 |
| 281 | 4mmol·l | 1 |
| 282 | or=25.0kg/m | 1 |
| 283 | pc3m | 3 |
| 284 | 1229.55m | 1 |
| 285 | σ-valerolactam | 1 |
| 286 | 0.5cm | 2 |
| 287 | colo320dm | 3 |
| 288 | /stem | 1 |
| 289 | rm-im | 1 |
| 290 | cd56dim | 1 |
| 291 | 2-meim | 1 |
| 292 | 2-etim | 1 |
| 293 | 8000/mm | 1 |
| 294 | /=100/mm | 1 |
| 295 | or=100/mm | 1 |
| 296 | 400/mm | 1 |
| 297 | 10/mm | 1 |
| 298 | 20leukocytes/mm | 1 |
| 299 | 200cells/mm | 1 |
| 300 | 135mm | 2 |
| 301 | 85bpm | 1 |
| 302 | /lithium | 1 |
| 303 | dose/maximum | 1 |
| 304 | svc+can | 7 |
| 305 | cs+svc+can | 2 |
| 306 | esfahan | 1 |
| 307 | gilan | 1 |
| 308 | cspleen | 1 |
| 309 | 85/min | 1 |
| 310 | 18/min | 3 |
| 311 | 85beats/min | 1 |
| 312 | cm-30min | 1 |
| 313 | cm-240min | 1 |
| 314 | cc-60min | 1 |
| 315 | cm-60min | 1 |
| 316 | cc-5min | 1 |
| 317 | cm-5min | 1 |
| 318 | amixin | 3 |
| 319 | 2xuln | 1 |
| 320 | time-to-stabilisation | 2 |
| 321 | fixed-flexion | 1 |
| 322 | ccd-18co | 7 |
| 323 | eca‑109/neo | 1 |
| 324 | cd127lo | 4 |
| 325 | 1/ro | 4 |
| 326 | -hnis/tdtomato | 1 |
| 327 | pto | 18 |
| 328 | tyr-p | 4 |
| 329 | vcap | 5 |
| 330 | c-cup | 2 |
| 331 | a431-cck2r | 1 |
| 332 | alpha2a-ar | 1 |
| 333 | alpha2b-ar | 1 |
| 334 | lymphomononuclear | 1 |
| 335 | on-bipolar | 2 |
| 336 | leger | 2 |
| 337 | xylan-chitooligomer | 2 |
| 338 | non-parameter | 1 |
| 339 | u87mg.δegfr | 1 |
| 340 | bushehr | 1 |
| 341 | tapir | 2 |
| 342 | ept-phbv-s | 1 |
| 343 | 12m/s | 1 |
| 344 | zr-75-1s | 2 |
| 345 | or=as | 2 |
| 346 | leukocyte/bands | 1 |
| 347 | glides | 6 |
| 348 | -t-lymphocytes | 1 |
| 349 | neutrophil-endotheliocytes | 1 |
| 350 | activitives | 1 |
| 351 | pes~zes | 1 |
| 352 | /=10.8cms | 1 |
| 353 | 30yrs | 1 |
| 354 | 25-≤30yrs | 1 |
| 355 | 20-≤25yrs | 1 |
| 356 | q-tests | 1 |
| 357 | micronucleous | 2 |
| 358 | /squamous | 1 |
| 359 | w/continuous | 1 |
| 360 | equus | 8 |
| 361 | bshvs | 3 |
| 362 | nlys | 3 |
| 363 | t | 20,473 |
| 364 | beta+t | 1 |
| 365 | mac-t | 1 |
| 366 | sample-t | 1 |
| 367 | anti-t | 6 |
| 368 | 2/t | 3 |
| 369 | par-1a/t | 2 |
| 370 | -293t | 1 |
| 371 | a-mechanoheat | 1 |
| 372 | bourgelat | 1 |
| 373 | fna-mct | 1 |
| 374 | hnet | 3 |
| 375 | r-dependent | 2 |
| 376 | munc18-1-deficient | 1 |
| 377 | patriot | 1 |
| 378 | cheart | 1 |
| 379 | αβt | 3 |
| 380 | or=cu | 1 |
| 381 | nleu | 2 |
| 382 | chl/iu | 2 |
| 383 | dutugemunu | 1 |
| 384 | coldwu | 1 |
| 385 | tcg=tcg+av | 1 |
| 386 | nflv | 3 |
| 387 | chochinov | 1 |
| 388 | smear/hpv | 1 |
| 389 | bme-uv | 2 |
| 390 | albustix | 2 |
| 391 | pan-tnox | 1 |
| 392 | ==10mg/day | 1 |
| 393 | 1×/day | 1 |
| 394 | ckidney | 1 |
| 395 | t-regulatory | 15 |
| 396 | line-1/lacz | 2 |
| 397 | mφ | 9 |
| 398 | carehpv™ | 2 |
| 399 | 3.2-2.62å | 1 |
| 400 | 3.2-2.67å | 1 |
| 401 | e≡∫ | 1 |
| 402 | αklothoβ | 1 |
| 403 | 30×10³ | 1 |
| 404 | 3×10³ | 2 |